In this Issue
The datasets, guidelines, and regulatory and reimbursement decisions shaping the practice of carotid revascularization.
CHIEF MEDICAL EDITOR’S PAGE
By Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD, and William A. Gray, MD
Both United States and European datasets suggest that practice makes perfect for carotid artery stenting.
By Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD
Comparing and contrasting the AHA, NICE, and ESVS guidelines.
By Simon K. Neequaye, BSc, MSc, MRCS; Alison W. Halliday, MS, FRCS; and Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD
CREST Principal Investigator Thomas G. Brott, MD, and Project Director Alice Sheffet, PhD, address a few of the common questions regarding the landmark carotid revascularization trial.
Implications of the new FDA approval in the United States.
By Chuck Simonton, MD, and Patrick Verta, MD
A look at the reimbursement history of carotid stenting in the United States, as well as the potential impact of CMS’s next move.
By Randel Richner, MPH, and Daniel Tuden, PhD
Clinical or subclinical MI predicts mortality after carotid intervention and should be included in the primary endpoint composite of carotid trials.
By Peter Kan, MD, MPH; Travis M. Dumont, MD; Adib A. Anla, MD; Adnan H. Siddiqui, MD, PhD; Elad I. Levy, MD; and L. Nelson Hopkins, MD
FEATURED TECHNOLOGYSponsored by Endologix, Inc.
Advanced Anatomical Fixation
By Matthew Jung, MD
IMAGING & DIAGNOSTICS
Techniques for improving safety and efficacy in the use of carbon dioxide as a contrast agent for evaluation and treatment of lower extremity arterial disease.
By Jason Q. Alexander, MD
A brief look at the development of these devices and their potential utility in the treatment of intracranial aneurysms.
By Giuseppe Lanzino, MD
A preview of today’s new products
Director and Founder of the Annual Fellows Course in Venous Disease shares his thoughts on the growing venous intervention arena in terms of physician education and how to integrate this specialty into your practice.